JBS N.V. filings document the reporting of a foreign private issuer with common shares listed on the NYSE and Brazilian depositary receipts referenced in shareholder materials. The record includes Form 6-K current reports, Form 20-F annual-report notices, audited consolidated financial statements, IFRS operating results, liquidity and capital resources, capital-structure information and dividend disclosures.
JBS filing exhibits also cover annual general meeting materials, shareholder voting results, board composition matters, director reappointments, adoption of annual accounts and discussion of the Dutch Corporate Governance Code. Investor presentations and earnings releases describe the company's global protein operations, reportable segments, forward-looking statement assumptions and financial performance across its food production and branded product portfolio.
JBS N.V. reported that it issued an earnings release for the quarter ended June 30, 2026, and detailed a planned leadership transition. The company will appoint Wesley Batista Filho, 34, as Global CEO effective January 2027. He has spent 15 years at JBS in senior roles, including CEO of JBS Brazil, President of Seara and, since 2023, CEO of JBS USA. The filing states there are no arrangements or related party transactions requiring disclosure in connection with his appointment, and that he will receive a base salary, annual bonus eligibility and equity awards under the long-term incentive plan.
Gilberto Tomazoni, 67, will step down as Global CEO in January 2027 after 14 years with the company, including eight as Global CEO, and will become Vice Chairman of the Board and Senior Advisor while remaining Chairman of Pilgrim’s Pride Corporation. During his tenure, JBS revenue grew 73%, from US$49.7 billion to US$86.2 billion, and the company obtained investment-grade status and a New York Stock Exchange listing.
JBS N.V., a Netherlands-based holding company for the global JBS Group, reports under IFRS and has voluntarily adopted U.S. domestic-style reporting on Form 10‑Q while retaining foreign private issuer status. For the six months ended June 30, 2026, net revenue was US$45.5 billion, up from US$40.5 billion a year earlier, driven across Brazil, Seara, Pilgrim’s Pride and Australia.
Despite higher revenue, net income fell sharply to US$145 million from US$1.15 billion, as gross profit declined, net finance expense rose to US$1.01 billion and early extinguishment of debt generated US$171.6 million of financial costs. The second quarter showed a net loss of US$96 million. Adjusted EBITDA for the half-year was US$2.56 billion, with Beef North America remaining loss-making on this measure.
Cash and cash equivalents were US$3.47 billion, down from US$4.57 billion at year-end, with net cash from operating activities only US$62.8 million after US$810.8 million of interest paid. Total loans and financing reached US$22.65 billion. The Board approved and paid a sizeable US$1.00 per share dividend (US$1.07 billion). Subsequent events include a planned US$77.3 million infrastructure debenture issue in Brazil, transfer of CRA obligations within the group, a US$2.5 billion joint venture with Indonesia’s DIM for Asia-Pacific protein investments, and a planned CEO transition effective January 2027.
JBS N.V., through subsidiary JBS USA Holding Lux S.à r.l., has entered a partnership with PT Danantara Investment Management, the investment arm of Indonesia’s sovereign wealth fund, to form a joint venture targeting protein production investments in Indonesia, other Southeast Asian markets, Australia and New Zealand. These regions account for approximately 745 million people, or 9.2% of the global population.
The Indonesian sovereign fund, via DIM, is committing USD$2.5 billion to the joint venture, with an Acquisition Plan guiding deployment; for three years after completion, DIM may be called to fund opportunities out of a remaining USD$1.7 billion commitment. A share adjustment allows DIM compensatory shares if average 2026–2027 EBITDA is below 2025, capped so its stake does not exceed 30%.
The Joint Venture Company will have a one-tier board of up to seven directors, with JBS nominating two executive and three non-executive directors and DIM nominating two non-executive directors. For the first three years, DIM is deemed to hold 25% for governance and economic purposes if its actual stake exceeds 7.5%. There is a mutual five-year lock up, followed by customary transfer rights including right of first offer, drag-along and tag-along rights. The parties intend an IPO; if no IPO occurs by the sixth anniversary of completion, DIM may, on up to two occasions, exchange some or all of its joint venture shares for newly issued JBS shares. Completion is conditional on regulatory approvals, JBS contributing its Australia and New Zealand business to the joint venture, and other customary closing conditions.
JBS N.V., together with certain subsidiaries including JBS S.A., entered into a Sixth Amendment and Restatement Agreement to its Revolving Syndicated Facility Agreement, creating an Amended Credit Agreement for a senior unsecured revolving credit facility with an aggregate principal committed amount of up to US$2.65 billion, available in multiple currencies and maturing in 2031 with a possible additional two-year renewal subject to lender consent.
Through this amendment, JBS N.V. and its subsidiaries expanded the group’s total revolving credit facilities by US$650 million, increasing overall availability from US$3.5 billion to US$4.2 billion, which the company describes as reinforcing its total liquidity.
JBS N.V. provides a Brazilian Corporate Governance Report prepared under CVM Resolution 80/2022, following Annex D and the Brazilian Corporate Governance Code for Listed Companies in a “practice or explain” format. The report is updated and submitted to the CVM by July 31 each year and covers voting structure, shareholder rights, board functioning, controls and ethics.
The company discloses a dual-class capital structure: Class A shares trade in the United States with 1 vote per share, while non‑listed Class B shares carry 10 votes per share, so the recommendation that capital consist only of ordinary shares with one vote each is marked “No”. Most other recommendations are marked “Yes”, including policies on profit allocation, shareholder engagement, board independence and diversity, performance evaluations, remuneration, risk management, audit and internal controls, code of conduct, whistleblowing, conflicts of interest, related-party transactions and securities trading. Some items are “Partial”, such as equal-treatment takeover bid provisions and board opinions on bids (addressed through Dutch corporate law and U.S. tender offer rules), CEO succession arrangements handled mainly by the Nomination Committee and Global CEO, and governance over political contributions via the Ethics Committee.
JBS N.V. has made a new investor presentation available on its website. The presentation, posted on June 15, 2026, will be used at investor conferences and in meetings with investors and others. The company clarifies that website content is not automatically incorporated into its securities filings.
Cavalcanti Guilherme Perboyre reported acquisition or exercise transactions in this Form 4 filing.
JBS N.V. granted Global CFO and Investor Relations Officer Guilherme Perboyre Cavalcanti 112,098 restricted stock units (RSUs) on June 9, 2026. Each RSU represents the right to receive one Class A common share or one Brazilian Depositary Receipt, with each BDR representing one Class A share.
The RSUs will vest in three equal annual installments on March 1, 2027, March 1, 2028, and March 1, 2029, subject to his continued employment. Following this award, he holds 112,098 RSUs directly, reflecting a compensation grant rather than an open-market transaction.
O'Callaghan Jeremiah Alphonsus reported acquisition or exercise transactions in this Form 4 filing.
JBS N.V. director Jeremiah Alphonsus O'Callaghan received two grants of restricted stock units on May 21, 2026, covering 27,228 and 49,554 RSUs. Each RSU represents the right to receive one Class A common share or one Brazilian Depositary Receipt.
The 27,228 RSUs will vest in equal parts on March 1, 2027, March 1, 2028 and March 1, 2029, subject to continued employment. The 49,554 RSUs will vest in equal parts on August 1, 2026, August 1, 2027 and August 1, 2028, also contingent on continued employment with JBS N.V.
Cavalcanti Guilherme Perboyre reported acquisition or exercise transactions in this Form 4 filing.
JBS N.V. reported that Global CFO and IRO Guilherme Perboyre Cavalcanti received a grant of 185,828 restricted stock units as equity compensation. Each RSU represents the right to receive one Class A common share or one Brazilian Depositary Receipt. These RSUs were granted on May 21, 2026 and will vest in three equal installments on March 1, 2027, March 1, 2028 and March 1, 2029, subject to continued employment. Following this award, Cavalcanti is shown holding 185,828 RSUs directly.
JBS N.V. announced that its Board of Directors approved a cash dividend of USD 1.00 per common share, to be paid from retained earnings reserves. The dividend will be paid on June 17, 2026 to shareholders of record at the close of business on May 18, 2026.
Holders of the Company’s Brazilian Depositary Receipts are estimated to receive a gross dividend of R$ 4.91 per BDR, based on the PTAX exchange rate of R$ 4.91 on May 13, 2026, with payment expected on June 22, 2026. Applicable taxes will be deducted, including a 15% Dutch withholding tax and IOF on the foreign exchange transaction for BDR holders.